113 related articles for article (PubMed ID: 9492061)
1. Osteoclasts from human giant cell tumors of bone lack estrogen receptors.
Collier FM; Huang WH; Holloway WR; Hodge JM; Gillespie MT; Daniels LL; Zheng MH; Nicholson GC
Endocrinology; 1998 Mar; 139(3):1258-67. PubMed ID: 9492061
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage.
Oreffo RO; Kusec V; Virdi AS; Flanagan AM; Grano M; Zambonin-Zallone A; Triffitt JT
Histochem Cell Biol; 1999 Feb; 111(2):125-33. PubMed ID: 10090573
[TBL] [Abstract][Full Text] [Related]
3. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.
Takahashi S; Goldring S; Katz M; Hilsenbeck S; Williams R; Roodman GD
J Clin Invest; 1995 Jan; 95(1):167-71. PubMed ID: 7814611
[TBL] [Abstract][Full Text] [Related]
5. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
6. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA.
Rakopoulos M; Ikegame M; Findlay DM; Martin TJ; Moseley JM
Bone; 1995 Nov; 17(5):447-53. PubMed ID: 8579955
[TBL] [Abstract][Full Text] [Related]
7. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.
Oursler MJ; Pederson L; Fitzpatrick L; Riggs BL; Spelsberg T
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5227-31. PubMed ID: 8202473
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
9. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.
Gorn AH; Rudolph SM; Flannery MR; Morton CC; Weremowicz S; Wang TZ; Krane SM; Goldring SR
J Clin Invest; 1995 Jun; 95(6):2680-91. PubMed ID: 7769107
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
[TBL] [Abstract][Full Text] [Related]
11. Detection of estrogen receptor alpha, carbonic anhydrase II and tartrate-resistant acid phosphatase mRNAs in putative mononuclear osteoclast precursor cells of neonatal rats by fluorescence in situ hybridization.
Huang WH; Lau AT; Daniels LL; Fujii H; Seydel U; Wood DJ; Papadimitriou JM; Zheng MH
J Mol Endocrinol; 1998 Apr; 20(2):211-9. PubMed ID: 9584836
[TBL] [Abstract][Full Text] [Related]
12. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
Bodine PV; Harris HA; Komm BS
Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
[TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptor beta in rat bone.
Onoe Y; Miyaura C; Ohta H; Nozawa S; Suda T
Endocrinology; 1997 Oct; 138(10):4509-12. PubMed ID: 9322974
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins.
Byers M; Kuiper GG; Gustafsson JA; Park-Sarge OK
Mol Endocrinol; 1997 Feb; 11(2):172-82. PubMed ID: 9013764
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin receptor isoforms in mouse and rat osteoclasts.
Ikegame M; Rakopoulos M; Zhou H; Houssami S; Martin TJ; Moseley JM; Findlay DM
J Bone Miner Res; 1995 Jan; 10(1):59-65. PubMed ID: 7747631
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the estrogen receptors alpha and beta in the rat corpus luteum of pregnancy: regulation by prolactin and placental lactogens.
Telleria CM; Zhong L; Deb S; Srivastava RK; Park KS; Sugino N; Park-Sarge OK; Gibori G
Endocrinology; 1998 May; 139(5):2432-42. PubMed ID: 9564855
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction.
Hoyland JA; Mee AP; Baird P; Braidman IP; Mawer EB; Freemont AJ
Bone; 1997 Feb; 20(2):87-92. PubMed ID: 9028531
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
20. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.
Miyamoto N; Higuchi Y; Tajima M; Ito M; Tsurudome M; Nishio M; Kawano M; Sudo A; Uchida A; Ito Y
J Orthop Res; 2000 Jul; 18(4):647-54. PubMed ID: 11052502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
